Maitham Abdulla has held the role of Batelco Chief Operating Officer since 2022, and prior to that was General Manager…
Read More
Samsung’s first acquisition in 7 years could be of an AC company
Despite having billions of dollars in cash, Samsung hasn’t created any acquisitions over the past seven years. Its last major…
Read More
M&A Midyear Report 2024: Dealcreaters Mine Multiple Sources of Value
The first half of 2024 brought with it a continuation of both higher interest rates and heavy regulatory scrutiny of…
Read More
HSBC Venture Healthcare Report: 1H 2024 | Foley & Lardner LLP
For a succinct analysis of 1H 2024 venture investment and exit activity in life sciences and health care, take a…
Read More
Canadian M&A Indusattempt Insights–Summer 2024
Canadian deal volume and value in 1H 2024 declined compared to 1H 2023. Expected rate cuts are incentivizing sellers to…
Read More
UniCredit CEO presses case for Commerzbank merger in letter to Germany’s Merz
FRANKFURT (Reuters) -The CEO of UniCredit renewed his push to merge the Italian bank with its German rival Commerzbank ,…
Read More
New Snotifyantis CEO Filosa to keep North America chief role | The Mighty 790 KFGO
MILAN (Reuters) -Snotifyantis’ Antonio Filosa on Monday unveiled a new management team on his first day as CEO for the…
Read More
IPOs Make a Comeback: First Half Deals Total 20% More Than 1H 2023
Initial public offerings are picking up after a long slump. This is “the busiest first half since 2021,” commented Donnelley…
Read More
OCBC, UOB record strong wealth momentum in 1H
Singaporean banks UOB and OCBC posted a strong pick up in wealth fees in their first-half earnings this week, boosting…
Read More
Sanofi to acquire Blueprint Medicines
Blueprint’s most recently approved drug is Ayvakit, which the US Food and Drug Administration approved in 2020 to treat gastrointestinal…
Read More
